Convection-enhanced delivery of ACNU with systemic administration of temozolomide
Project/Area Number |
20390378
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Cerebral neurosurgery
|
Research Institution | Tohoku University |
Principal Investigator |
SONODA Yukihiko Tohoku University, 大学院・医学系研究科, 非常勤講師 (90302140)
|
Co-Investigator(Kenkyū-buntansha) |
YAMASHITA Yoji 宮城県がんセンター研究所, 特任研究員 (30420045)
金森 政之 東北大学, 大学院・医学系研究科, 助教 (60420022)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥8,710,000 (Direct Cost: ¥6,700,000、Indirect Cost: ¥2,010,000)
Fiscal Year 2010: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2009: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2008: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | 膠芽腫 / MGMT CED法 / 薬剤耐性 / MGMT / CED法 / ACNU / Temozolomide |
Research Abstract |
This study evaluated the efficacy of combined-modality treatments using CED of ACNU with systemic administration of temozolomide. CED of ACNU plus systemic administration of temozolomide significantly enhanced survival rate compared with each treatment alone (versus CED : p<0.001, versus systemic temozolomide : p<0.05). Multimodality treatment using CED of ACNU and systemic chemotherapy with temozolomide is a promising strategy for treatment of brain tumors.
|
Report
(4 results)
Research Products
(8 results)